← FDA DRUG APPROVALS

FDA ANDA · ANDA201947

MORPHINE SULFATE

Sponsor: VISTAPHARM

APPLICATION
ANDA201947
TYPE
ANDA
ORIGINAL APPROVAL
2012-01-05
LATEST ACTION
2018-09-18
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

MORPHINE SULFATEDiscontinued
MORPHINE SULFATE 10MG/5ML · SOLUTION · ORAL
MORPHINE SULFATEDiscontinued
MORPHINE SULFATE 20MG/5ML · SOLUTION · ORAL

Approval history

2018-09-18REMS · Supplement 4AP
2012-01-05Not Applicable · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →